Back to results
US 8,524,710 B2Granted
Pyrrolidine derivatives
AssigneeHoffmann-La Roche Inc.
InventorsDavid Banner, Uwe Grether, Wolfgang Haap, Holger Kuehne, Harald Mauser, Jean-Marc Plancher
Life of this patent
Estimating the term…
Abstract
The invention relates to a compound of formula (I) wherein A1 to A4 and R1 to R6 are defined as in the description and in the claims. The compound of formula (I) can be used, for example, as inhibitors of the cysteine protease cathepsin.
Claims32
A compound of formula (I)
- wherein
- R1 is selected from the group consisting of hydrogen, alkyl, morpholinyl, haloalkylamino, alkyloxadiazolyl, hydroxyl, halopyrrolidinyl, azetidinyl, alkylamino, amino, cyanoalkylamino, halophenylalkylamino and cyanocycloalkylamino;
- R2, R3, R4, R5 and R6 are each independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, alkoxy, haloalkyloxy, halogen, hydroxyl, cyanopyrazinyloxy, pyrazolyl, alkylpyrazolyl, imidazolyl, benzoimidazolyl, 6-oxo-6H-pyridazinyl, alkyl-6-oxo-6H-pyridazinyl, piperazinyl, N-alkylpiperazinyl, piperidinyl, difluoropyrrolidinyl, phenylimidazolyl, oxo-pyrrolidinyl, oxo-oxazolidinyl, morpholinyl, oxo-morpholinyl, oxo-pyridinyl, 2-oxo-2H-pyrazinyl, difluoropiperidinyl, haloalkylpiperidinyl, piperidinylalkoxy, oxetanyloxy, alkylpyrazolyl, halopyridinyl, alkylpyridinyl, cycloalkyl, cycloalkylalkyl, halophenyl, alkylcarbonylaminocycloalkylalkyl, haloalkylpiperazinyl, alkylamino, alkoxyalkylpiperazinyl, cycloalkylpiperazinyl, hexahydropyrrolo[1,2-a]pyrazinyl, 5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl, alkylimidazolyl, azetidinyl, cycloalkylpiperazinyl, alkylimidazolyl, alkoxyalkoxy, imidazo[4,5-c]pyridinyl, alkylpiperazinyl, hexahydro-pyrrolo[1,2-a]pyrazinyl, haloazetidinyl, pyrimindinyl and alkenyloxy;
- A1 is —CH2—, carbonyl, —C(O)O— or absent;
- A2 is nitrogen or CR7;
- A3 is nitrogen or CR8;
- A4 is nitrogen or CR9;
- R7 is selected from the group consisting of hydrogen, alkyl, haloalkyl, halogen, hydroxyl, haloalkylaminocarbonyl;
- halophenylalkylaminocarbonyl, phenylcycloalkylaminocarbonyl, haloalkylphenylalkylaminocarbonyl, halophenylcycloalkylaminocarbonyl and halophenylcycloalkylalkylaminocarbonyl;
- R8 is selected from the group consisting of hydrogen, alkyl, haloalkyl, halogen and hydroxyl;
- or R7 and R8 together with the carbon atom to which they are attached form cycloalkyl or substituted pyrrolidine, wherein substituted pyrrolidine is pyrrolidine N-substituted with haloalkyl or formyl;
- R9 is selected from the group consisting of hydrogen, alkyl, haloalkyl, halogen and nitro;
- or R8 and R9 together with the carbon atom to which they are attached form cycloalkyl;
- or a pharmaceutically acceptable salt thereof.
11 more elements
Dependencies are inferred from the claim text.